Tyrosine kinase inhibitors (TKIs) are associated with prolongation of the QTc interval on the electrocardiogram (ECG). The QTc-interval prolongation increases the risk of life-threatening arrhythmias.
In allogeneic HSCT, a therapeutic effect generally follows provision of normal, ordered, donor-derived hematopoiesis after successful engraftment of hematopoietic stem cells. Patients undergo pre-HSCT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback